A Phase 4 interventional study of MRI and Gadavist 2Ml Solution for Injection in Image, Body, sponsored by Northwestern University. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-15.
Sponsored by Northwestern University · Phase 4, Interventional, and Diagnostic
Patients and healthy volunteers will be scanned in order to test new sequences.
The aims of this study are to:
Northwestern University is the lead sponsor of 1,396 studies on the registry; 199 are open to participants now.
Of its 102 completed or terminated interventional studies of FDA-regulated products, 73 (72%) have results posted.
Counted across the registry records on this site, refreshed daily.
At least 18 years of age
Exclusion Criteria:
When contrast is being administered: subjects with a GFR \< 30 ml/min
Patients will add 15 minutes to their SOC MRI for research purposes
Radiation: MRI · Drug: Gadavist 2Ml Solution for Injection
Patients will add 15 minutes to their SOC MRI for research purposes
Radiation: MRI
Volunteers undergo 1 research MRI for research purposes
Radiation: MRI · Drug: Gadavist 2Ml Solution for Injection
Volunteers undergo 1 research MRI for research purposes
Radiation: MRI
1.5T or 3T MRI scanner (Siemens Medical Systems)
Arm 1 and Arm 3 subjects will undergo this intervention (Gadavist 2Ml solution)
Conduct clinical protocol development and validation
Testing of new MRI pulse sequences will be performed for validation of potential new diagnostic capabilities. The MRI pulse sequences will be routinely performed along with clinically-validated and accepted pulse sequences for comparison of the novel sequences in human subjects (patients and healthy volunteers). Novel sequences will be performed in the accepted method with adjustment of settings to evaluate image qualities and normative values produced by the MRI machine. The resulting images provided by the novel sequences will be able to evaluated for diagnostic quality and to obtain comparison of possible improvements alongside clinically-validated MRI pulse sequences.
Time frame: 5 years
Demonstrate and train
Human subjects may be scanned utilizing MRI pulse sequences in the context of a clinical assessment for demonstrating of equipment or sequence function for training of MRI technologist. The sequence will be performed by a skilled technologist with the primary goal of providing information on proper utilizing of MRI hardware and software for technologist who are training and will be possibly utilizing these technique to provided safe and effective use of MRI systems and their software.
Time frame: 5 years
Plan to share: Yes — The research team may use the data obtained from this study for future institutionally approved studies not yet identified but conducted by Feinberg School of Medicine investigators. This means that information about you, including your name, date of birth, study data, etc. may be given to investigators not currently working on this study.
Supporting information: Icf
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Northwestern University